Oxitec

Oxitec
Industry Biotechnology, Pest Control
Founded Oxford, United Kingdom (2002 (2002))
Key people
  • Hadyn Parry (CEO)

,[1] Luke Alphey (Founder)

Website oxitec.com

Oxitec (orig. Oxford Insect Technologies) is a British biotechnology company which develops genetically modified insects to assist in insect control. Oxitec is working to develop a genetic modified version of Aedes aegypti to help control the transmission mosquito borne diseases.[2][3]

History

Oxitec was started in 2002 by Oxford University's Isis Innovation technology transfer company.[1][4] In August 2015 Oxitec was purchased by U.S.-based Intrexon Corp in a deal valued at $160 million.[5]

See also

References

  1. 1 2 Cookson, Clive (23 April 2015). "‘Lethal gene’ to combat malaria relies on laws of attraction". Financial Times. Retrieved 22 May 2015.
  2. ↑ Free, Stephen (16 May 2015). "Can genetically modified mosquitoes curb Dengue fever?". PBS NewsHour. Retrieved 22 May 2015.
  3. ↑ Jennings, Christian (28 April 2015). "Mosquitoes Really Do Prefer Some People to Others, Say Scientists". Newsweek. Retrieved 22 May 2015.
  4. ↑ Solon, Olivia (25 April 2012). "Oxford academics tentatively embrace startup culture". Wired UK. Retrieved 22 May 2015.
  5. ↑ Nickel, Rod (15 September 2015). "Market turbulence or not, North American investors plow into farm tech". Reuters. Retrieved 9 October 2015.

External Links

This article is issued from Wikipedia - version of the Sunday, January 31, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.